Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072526 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
A Phase 2 study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT01072526 is a Phase 2 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 7 participants.
The verdict
NCT01072526, a Phase 2 study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a homeopathic therapy in combination with cyclosporin (Restasis) is more effective than cyclosporin (Restasis) alone in the treatment of dry eye disease.
Interventions
- DRUG Euphrasia-based homeopathic therapy
- DRUG Cyclosporin solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072526
The ClinicalTrials.gov registry entry for NCT01072526 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Euphrasia-based homeopathic therapy is the first listed.
NCT01072526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01072526 about?
NCT01072526 is a clinical study titled "Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease". The purpose of this study is to determine whether a homeopathic therapy in combination with cyclosporin (Restasis) is more effective than cyclosporin (Restasis) alone in the treatment of dry eye disease.
What is the current status of trial NCT01072526?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2007-12. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01072526?
The interventions under investigation include: Euphrasia-based homeopathic therapy (DRUG), Cyclosporin solution (DRUG).
Who is sponsoring clinical trial NCT01072526?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.